mitomycin has been researched along with Leukemia, Lymphocytic in 5 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The generation time of this cancer cell line had a distribution with a long tail and a heritability across generations." | 1.62 | Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug. ( Nakaoka, H; Okura, R; Seita, A; Wakamoto, Y, 2021) |
| "Mitomycin C-treated null cell ALL blasts from two of five children suppressed the proliferative responses of normal responder cells by 80% and 58% whereas those from two other children enhanced the responses by 118% and 31%." | 1.26 | Immunoregulation by blasts from null cell and T-cell leukemias: help and suppression of T-cell proliferative responses to mitogens. ( Good, RA; Gupta, S; Kaur, P; Miller, DR; Schulof, RS; Steinherz, P, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seita, A | 1 |
| Nakaoka, H | 1 |
| Okura, R | 1 |
| Wakamoto, Y | 1 |
| SAMPEY, JR | 1 |
| WAKISAKA, G | 1 |
| UCHINO, H | 1 |
| NAKAMURA, T | 1 |
| SHIRAKAWA, S | 1 |
| ADACHI, A | 1 |
| SAKURAI, M | 1 |
| MIYAMOTO, K | 1 |
| Kaur, P | 1 |
| Schulof, RS | 1 |
| Miller, DR | 1 |
| Steinherz, P | 1 |
| Good, RA | 1 |
| Gupta, S | 1 |
| Dai, YC | 1 |
| Hu, GZ | 1 |
| Niu, HY | 1 |
| Wen, Z | 1 |
| Fang, Z | 1 |
| Lu, XG | 1 |
| Li, J | 1 |
| Wu, Q | 1 |
| Huang, YP | 1 |
| Wen, R | 1 |
5 other studies available for mitomycin and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Leu | 2021 |
Antibiotics in the control of Hodgkin's disease and the leukemias.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Azaserine; Dactinomycin; Hodgkin Disease; Humans | 1962 |
PRESENT STATUS OF LEUKEMIA IN JAPAN WITH SPECIAL REFERENCE TO EPIDEMIOLOGY AND STUDIES ON THE EFFECT OF CHEMOTHERAPY.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Asian People; Busulfan; DNA; DNA, Neoplasm; Epidemio | 1964 |
Immunoregulation by blasts from null cell and T-cell leukemias: help and suppression of T-cell proliferative responses to mitogens.
Topics: Adolescent; Bone Marrow; Cell Division; Cells, Cultured; Child; Child, Preschool; Concanavalin A; Fe | 1982 |
Formation of lymphocyte colonies under serum-free culture conditions in normal individuals and patients with chronic lymphocytic leukemia.
Topics: B-Lymphocytes; Cells, Cultured; Culture Media; Culture Techniques; Humans; Leukemia, Lymphoid; Mitom | 1987 |